Iveric's Zimura Succeeds In Dry AMD Study

Stock Sees Three-Day Gain Of 283%

 
• By Kevin Grogan
  
Eyes
The eyes have it for Iveric • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Sensory

More from Therapeutic Category